deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT02267538

Dexmedetomidine and Delirium in Patients After Cardiac Surgery

Impact of Dexmedetomidine on the Incidence of Postoperative Delirium in Patients After Cardiac Surgery: a Randomized, Double-blinded, and Placebo-controlled Clinical Trial

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital

Conditions C.Surgical Procedure; Cardiac Delirium Postoperative Complications
Interventions 0.9% sodium chloride for injection dexmedetomidine hydrochloride for injection
Updated 9 times since 2017 Last updated: Feb 3, 2018 Started: Nov 30, 2014 Primary completion: Aug 31, 2015 Completion: Nov 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates C.Surgical Procedure; Cardiac and Delirium and is currently completed. Chinese Academy of Medical Sciences, Fuwai Hospital leads this study, which shows 9 recorded versions since 2014 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Mar 2018 · 13 months · monthly snapshotCompleted~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 4 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  2. Mar 2018 — Jun 2018 [monthly]

    Completed PHASE4

  3. Feb 2017 — Mar 2018 [monthly]

    Completed PHASE4

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chinese Academy of Medical Sciences, Fuwai Hospital
  • Peking University First Hospital
Data source: Peking University First Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations